Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease.
about
Antioxidant vitamin and mineral supplements for preventing age-related macular degenerationAntioxidant vitamin and mineral supplements for preventing age-related macular degenerationRosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspectiveFrom C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for AtheroprotectionPeripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomesCriticial limb ischemia: epidemiologyHaemostasis, inflammation and renal function following exercise in patients with intermittent claudication on statin and aspirin therapyCritical appraisal of C-reactive protein throughout the spectrum of cardiovascular diseaseGene polymorphisms in association with emerging cardiovascular risk markers in adult womenCystatin C: a strong marker for lower limb ischemia in Chinese type 2 diabetic patients?Heart disease and stroke statistics--2011 update: a report from the American Heart AssociationHeart disease and stroke statistics--2012 update: a report from the American Heart AssociationPeripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study.Censored Data Analysis Reveals Effects of Age and Hepatitis C Infection on C-Reactive Protein Levels in Healthy Adult Chimpanzees (Pan troglodytes).A systematic comparison of the quality and volume of published data available on novel risk factors for stroke versus coronary heart disease.Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts.Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort.Lipid lowering and beyond: results from the CARE study on lipoproteins and inflammation. Cholesterol and Recurrent Events.The role of oxidative stress in atherosclerosis: the hope and the hypeEvaluation of C-reactive protein and interleukin-6 in the peripheral blood of patients with chronic periodontitis.Relation of genetic variation in the gene coding for C-reactive protein with its plasma protein concentrations: findings from the Women's Health Initiative Observational CohortAssociation of diabetic peripheral arterial disease and objectively-measured physical activity: NHANES 2003-2004.n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial.Relationship between the plasma concentration of C-reactive protein and severity of peripheral arterial diseaseAntioxidant vitamin and mineral supplementation for preventing age-related macular degeneration.Novel markers of peripheral arterial disease.The role of C-reactive protein in cardiovascular disease risk.Microorganisms in the aetiology of atherosclerosis.Peripheral vascular disease and type 2 diabetes mellitus.Hyperuricemia and incident cardiovascular disease and noncardiac vascular events in patients with rheumatoid arthritis.New developments in the detection of vulnerable plaque.Gender-specific risk factors for peripheral artery disease in a voluntary screening population.Physical activity, exercise, and inflammatory markers in older adults: findings from the Health, Aging and Body Composition Study.Mitral valve restenosis after percutaneous transmitral valvuloplasty, role of continuous inflammationPeripheral arterial disease, gender, and depression in the Heart and Soul StudyAssociation between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease.Statins in the 21st century: end of the simple story?Statins and inflammatory markers.Peripheral arterial disease--epidemiological aspects.Associates of cardiopulmonary arrest in the perihemodialytic period.
P2860
Q24202679-DBBC99FC-CC54-4B12-89EC-9A6B2A02143DQ24242709-D22E06AB-C706-436D-9E82-7164E25B35DDQ24594814-F5B347B2-6F51-4B12-9557-E006BCAE566DQ26770209-5DEA423D-D821-42F9-9B56-31A693870C6CQ26799591-A6CDE382-E911-4E20-9D75-DA9229776A6DQ27026881-E05B89A3-E972-41D2-B00C-4DF814228F34Q28199579-8CF5F167-3D4D-428A-911D-004A5867A182Q28219483-3ABD2A8B-5BF6-430D-AC82-BA0724F86923Q28393721-9EDB6667-E5BE-4744-8371-263EB2C823CBQ28534470-25060ED1-CF8C-49C1-9C87-FA6EEC1FF742Q29547236-ABF51BD2-D11C-4BDE-A9E7-6B028A338846Q29547909-ADF7A0B6-C74D-4463-BB40-CCAED135B3EEQ30595680-8A15C56D-6A87-441F-9FA1-30B0A681DEC9Q30990527-24F264AF-5360-4933-966C-A5B04CA715A8Q30998860-FCAD36FA-10EB-4874-ABF0-003370E646C5Q33377856-D4828809-44F9-4D3F-8E4B-3F3365E0DDC1Q33448450-F89EDA65-99DF-4907-A895-231BF70F1F23Q33545121-FFA776E4-6B48-42E7-98E9-45844F43D076Q33645001-4C713E13-AE0F-4AF9-9CB6-7F031E8D34D9Q33759879-B01D0D69-65DC-498A-80F0-8AE60AAC8068Q33797783-24FE99D9-2D5C-4834-B874-93AF50AE0753Q33803315-F30D59D5-2E5E-44E8-AB47-FBA7782C0559Q33819705-59A90C7A-AC08-40CA-AEA0-EF522CCC82F3Q33860219-85CF8571-277A-4A5C-B008-678CC784A1B6Q33909444-AC1D7354-1342-4FE0-B7FD-7DD64344AB3BQ33984026-99E1ABBD-810B-4B44-BFF2-FCE3875DEFBDQ34011157-462568AA-FE80-4684-8ED9-328DE31DF5F5Q34065709-9E858AE9-1B11-4BF7-A3E5-936322BD5DF4Q34071984-CAFD086D-BA2C-4C65-B5E4-AC906D5FDC2EQ34114277-CD122067-01FA-402B-B98B-2777946FD670Q34140725-C78559FD-BF51-4788-9426-1371C2E0738AQ34297119-0BE5F9B0-BBE5-4957-8F54-CF55587E4764Q34328248-37869A2A-5DC2-4CD6-B36A-5E76E4FFB18AQ34333491-80D0EBEF-B8AA-4259-85DB-BC4B73969DD1Q34349272-427BAE31-7091-4070-8D23-53D3A6AA2297Q34391653-AEA3366A-01D5-48ED-8C6B-B157D8526FA3Q34481748-6354E31E-4ADC-4341-942F-2D6407670971Q34482145-0BC7CBA0-726F-4F29-B042-A0B5C38C0AAAQ34492461-A5C850D4-EAA4-4A18-B1B6-A23B47C6D1AAQ34532711-8CC26BC3-6FA0-4801-A0E7-689FC8310373
P2860
Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Plasma concentration of C-reac ...... g peripheral vascular disease.
@en
type
label
Plasma concentration of C-reac ...... g peripheral vascular disease.
@en
prefLabel
Plasma concentration of C-reac ...... g peripheral vascular disease.
@en
P2093
P356
P1433
P1476
Plasma concentration of C-reac ...... g peripheral vascular disease.
@en
P2093
Hennekens CH
Stampfer MJ
P304
P356
10.1161/01.CIR.97.5.425
P407
P577
1998-02-01T00:00:00Z